A) | non-prescribing. | ||
B) | inadequate prescribing. | ||
C) | continued prescribing despite evidence of ineffectiveness of opioids. | ||
D) | All of the above |
A) | Prescription by telemedicine is unacceptable. | ||
B) | Obtaining a urine drug test should be deferred to follow-up visit. | ||
C) | Initial treatment should be presented as a trial for a pre-defined period. | ||
D) | A thorough clinical examination should be documented in the medical record. |
A) | establish a specific diagnosis, justify the need, and document the plan. | ||
B) | discuss treatment goals and educate the patient regarding benefits/risks. | ||
C) | conduct a thorough assessment, including past use of controlled medication and addiction risk. | ||
D) | All of the above |
A) | Low | ||
B) | Medium | ||
C) | High | ||
D) | Severe |
A) | consists of 5 items. | ||
B) | is patient administered. | ||
C) | diagnoses depression in the past month. | ||
D) | assesses the likelihood of current substance abuse. |
A) | 6 to 12 weeks. | ||
B) | 3 to 6 months. | ||
C) | 6 to 12 months. | ||
D) | 1 to 2 years. |
A) | burning. | ||
B) | throwing in the garbage in a sealed container. | ||
C) | sharing with a friend or relative with chronic pain. | ||
D) | depositing the drugs in permanent drug collection boxes located within law enforcement agencies. |
A) | a friend or relative for free. | ||
B) | a prescription from one doctor. | ||
C) | purchase from a drug dealer or other stranger. | ||
D) | theft from a doctor's office, clinic, hospital, or pharmacy. |
A) | Asking for specific medications | ||
B) | Injecting medications meant for oral use | ||
C) | Reluctance to decrease opioid dosing once stable | ||
D) | Stockpiling medications during times when pain is less severe |
A) | Institutes of Medicine | ||
B) | Office of National Drug Control Policy | ||
C) | U.S. Drug Enforcement Administration | ||
D) | U.S. Department of Health and Human Services |